Clinical Trial Update: Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ketamine for acutely suicidal patients in the emergency department was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Suicidal Ideation

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Naval Medical Center Camp Lejeune | Conditions: Suicide, Suicide Threat | Phase 3 | Status: TERMINATED | Results posted: 2024-11-19